Nuveen Asset Management, LLC Charles River Laboratories International, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 127,067 shares of CRL stock, worth $19.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

127,067

Previous 128,837 1.37%

Holding current value

$19.8 Million

Previous $25.4 Million 7.58%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$178.58 - $220.69 $316,086 - $390,621	-1,770 Reduced 1.37%	127,067 $23.5 Million
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $218,409 - $285,026	-1,162 Reduced 0.89%	128,837 $25.4 Million
Q2 2024 Aug 09, 2024	SELL	$206.39 - $268.73 $944,853 - $1.23 Million	-4,578 Reduced 3.4%	129,999 $26.9 Million
Q1 2024 May 13, 2024	SELL	$203.52 - $273.43 $9.4 Million - $12.6 Million	-46,173 Reduced 25.55%	134,577 $36.5 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $17,932 - $26,033	109 Added 0.06%	180,750 $42.7 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $332,686 - $372,330	-1,711 Reduced 0.94%	180,641 $35.4 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $6.32 Million - $7.23 Million	-34,393 Reduced 15.87%	182,352 $38.3 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $1.6 Million - $2.17 Million	8,337 Added 4.0%	216,745 $43.7 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $6.02 Million - $7.64 Million	-30,564 Reduced 12.79%	208,408 $45.4 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $12.9 Million - $17.7 Million	-70,742 Reduced 22.84%	238,972 $47 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $6.56 Million - $9.71 Million	-32,118 Reduced 9.4%	309,714 $66.3 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $17.5 Million - $24.8 Million	68,471 Added 25.05%	341,832 $98 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $7.38 Million - $9.43 Million	21,013 Added 8.33%	273,361 $103 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $11.6 Million - $14.3 Million	-31,205 Reduced 11.0%	252,348 $104 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $6.77 Million - $8.56 Million	23,029 Added 8.84%	283,553 $105 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $1.11 Million - $1.33 Million	-4,447 Reduced 1.68%	260,524 $75.5 Million
Q4 2020 May 17, 2021	BUY	$222.0 - $252.62 $1.11 Million - $1.27 Million	5,019 Added 1.93%	264,971 $66.2 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $13.4 Million - $15.3 Million	60,537 Added 30.36%	259,952 $65 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $1.25 Million - $1.61 Million	-7,118 Reduced 3.45%	199,415 $45.2 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $6.74 Million - $10.8 Million	-56,678 Reduced 21.53%	206,533 $36 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $11.2 Million - $20.2 Million	113,343 Added 75.63%	263,211 $33.2 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $3.31 Million - $4.01 Million	-26,225 Reduced 14.89%	149,868 $22.9 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $3.39 Million - $3.89 Million	-27,096 Reduced 13.34%	176,093 $23.3 Million
Q2 2019 Aug 15, 2019	BUY	$123.4 - $148.55 $24.4 Million - $29.4 Million	197,847 Added 3703.61%	203,189 $28.8 Million
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $62,108 - $74,535	554 Added 11.57%	5,342 $719,000
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $463,095 - $523,136	4,788	4,788 $517,000

Others Institutions Holding CRL

# of Institutions

709

Shares Held

49.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.91B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Charles River Laboratories International, Inc. Transaction History